Page last updated: 2024-09-04

beta-lactams and Pneumonia

beta-lactams has been researched along with Pneumonia in 72 studies

Research

Studies (72)

Timeframe	Studies, this research(%)	All Research%
pre-1990	8 (11.11)	18.7374
1990's	3 (4.17)	18.2507
2000's	15 (20.83)	29.6817
2010's	25 (34.72)	24.3611
2020's	21 (29.17)	2.80

Authors

Authors	Studies
Candel, FJ; González Del Castillo, J; Julián-Jiménez, A	1
Alvarez, CA; Anzueto, A; Metersky, M; Mohammed, T; Mortensen, EM; Uddin, M	1
Chambers, HF; Creech, CB; Evans, S; Fowler, VG; Gerber, JS; Hofto, ME; Huskins, WC; Kong, Y; Kwon, J; Martin, JM; Newland, JG; Pettigrew, MM; Staat, MA; Wade, M; Walter, EB; Williams, DJ	1
Chambers, HF; Creech, CB; Evans, S; Fowler, VG; Gent, JF; Gerber, JS; Hofto, ME; Huskins, WC; Kong, Y; Kwon, J; Martin, JM; Newland, JG; Pan, Q; Pettigrew, MM; Staat, MA; Wade, M; Walter, EB; Williams, DJ	1
Bridevaux, PO; Carballo, S; Chauffard, A; Garin, N; Prendki, V; Reny, JL; Stirnemann, J	1
Jiao, Y; Ma, L; Peng, XX; Wang, CC; Xu, LY; Zhang, L; Zhao, CZ	1
Hu, P; Li, X; Tang, Y; Tu, X; Wu, J; Xia, H; Xiao, T; Yan, K	1
Damås, JK; Heggelund, L; Tranung, M; Waagsbø, B	1
Axelrod, P; Holaday, E; Mishkin, A; Motzer, AR	1
Aldhahri, RK; Almadani, RM; Eljaaly, K; Gabb, SG; Shoaib, OA; Thabit, AK	1
Karpova, OY; Pigusova, NA; Rachina, SA; Sinopalnikov, AI; Vasilyeva, IS	1
Greco Kinney, A; Hadique, S; Jain, P; Kovacic Scherrer, N; Sarkar, S; Wen, S	1
Bae, S; Baek, AR; Baek, MS; Chang, Y; Cho, WH; Gil, HI; Hong, SB; Jeon, K; Kim, C; Kim, JH; Lee, HB; Lee, HK; Min, KH; Moon, JY; Oh, JY; Park, HK; Shin, B; Yoo, KH	1
Ahmed, N; Alamri, IA; Alfaraj, AH; Alissa, M; Almaghaslah, M; Almogbel, MS; Alotaibi, J; Alqahtani, SA; Engku Abd Rahman, ENS; Halawi, MY; Ibrahim, FA; Irekeola, AA; Rabaan, AA; Yean, CY; Zahari, NIN	1
Fan, H; Liu, S; Ma, Y; Tong, X; Wang, D	1
Ceccato, A; Gabarrus, A; Torres, A	1
Biais, M; Carrié, C; Chadefaux, G; de Courson, H; Nouette-Gaulain, K; Pereira, B; Petit, L; Sauvage, N	1
Davis, AM; Olson, G	1
Barker, CIS; Bielicki, J; Clements, M; Gastine, S; Hartmann, C; Hsia, Y; Sharland, M; Standing, JF	1
Gillani, SSA; Kanwal, Z; Malik, H; Pervaiz, I; Rafique, M; Rashid, F	1
Aegerter, P; Bedos, JP; Benhamou, D; Bouchand, F; Chinet, T; Claessens, YE; Crémieux, AC; Davido, B; de Lastours, V; Deconinck, L; Delcey, V; Diamantis, S; Dinh, A; Dombret, MC; Dumoulin, J; Duran, C; Grenet, J; Kahn, JE; Labarère, J; Lagrange, A; Makhloufi, S; Mathieu, E; Matt, M; Mellon, G; Pépin, M; Perronne, C; Renaud, B; Ropers, J; Rouveix, E; Senard, O; Vitrat, V	1
Brun-Buisson, C; Caserio-Schönemann, C; Cheysson, F; Guillemot, D; Le Fouler, L; Opatowski, L; Pontais, I; Watier, L	1
Broquet, A; Burghelea, A; Caroff, N; Crémet, L; Delanou, S; Leroy, AG; Muller, D; Roquilly, A	1
Bhowmick, T; Blumenthal, KG; Fu, X; Lee, F; Mancini, CM; Postelnick, M; Schulz, LT; Wimmer, M; Zhang, Y	1
Bonten, MJM; Oosterheert, JJ; Postma, DF; van de Garde, EMW; van Werkhoven, CH	1
Smith, MJ	1
Waterer, G	1
Horowitz, HW	1
Cao, B; Chen, L; Cui, X; Han, X; Li, H; Li, L; Li, Y; Liu, B; Liu, M; Liu, X; Purdy, JE; Suo, L; Wang, G; Wang, J; Wang, L; Wang, Y; Xiao, Y; Xing, X; Xue, C; Yao, X; Yu, G; Yu, H; Zhang, C; Zhou, F; Zhu, X	1
Månsson, V; Resman, F; Riesbeck, K; Thegerström, J	1
Aktaş Samur, A; Bilge, U; Çelenk, B; Çilli, A; Havlucu, Y; Hazar, A; Kılıç, Ö; Kılınç, O; Şakar Coşkun, A; Sayıner, A; Taşbakan, S; Tokgöz, F; Waterer, GW	1
Covvey, JR; Freedy, HR; Guarascio, AJ; Nemecek, BD; Wilson, L; Yassin, MH; Zimmerman, DE	1
Li, B; Nie, W; Xiu, Q	1
Bai, N; Cai, Y; Liang, B; Liu, Y; Sun, C; Wang, J; Wang, R; Zhang, L	1
Burki, TK	1
Efimov, NW; Miroshnikov, BI; Remizov, AS; Skipskiy, IM	1
Bravo-Ferrer, JM; Gutiérrez-Urbón, JM; Llinares, P; Pita, S; Ramos-Merino, L; Seoane-Pillado, T; Sousa, D; Vázquez-Rodríguez, P	1
Kim, HJ; Kim, YH; Lee, JH	1
Hasegawa, Y; Imaizumi, K; Maruyama, E; Ogawa, M; Ohashi, T; Sato, S; Shindo, Y	1
Low, DE	1
Athanassa, Z; Falagas, ME; Grammatikos, A; Korbila, IP; Siempos, II; Vardakas, KZ	1
Elias, N; Odeh, M; Sabetay, S; Sheikh-Ahmad, M; Slobodin, G; Weller, B; Zaygraikin, N	1
Drusano, GL; Esposito, S; Leone, S; Lucini, V; Ma, L; Pannacci, M; Scaglione, F	1
Aguilar, L; Barberán, J; González-Comeche, J; González-Moreno, J; González-Pina, B; Granizo, JJ; Irurzun, J; López-Dupla, M; Marín, A; Murcia, JM	1
Boersma, WG; van der Eerden, MM	1
Arnold, FW; Brock, GN; LaJoie, AS; Lopardo, G; Menéndez, R; Peyrani, P; Ramirez, JA; Rello, J; Rossi, P; Torres, A	1
He, C; Kazmierczak, BI; Lan, L; Murray, TS	1
Frei, CR; Restrepo, MI	1
Daoud, E; Guzman, J	1
Chen, TL; Fung, CP; Huang, LJ; Jeng, YY; Lin, YT; Liu, CY; Wang, FD	1
Beekmann, SE; Hersh, AL; Newland, JG; Polgreen, PM; Shah, SS; Shapiro, DJ	1
Bauer, TT; Ernen, C; Hauptmeier, BM; Hecht, J; Lepper, PM; Nüesch, E; Ott, SR; Pletz, MW; Welte, T	1
An, SC; Chen, JC; Gao, ZC; Jiang, N; Kang, Y; Wang, XR	1
Ala-Kokko, TI; Karhu, J; Ohtonen, P; Syrjälä, H	1
Blain, H; Durant, R; Jeandel, C; Raschilas, F; Tigoulet, F	1
Jayarao, BM; Sawant, AA; Sordillo, LM	1
Bodmann, KF	1
Wasielewski, S	1
De Vecchi, E; Drago, L; Gismondo, MR; Nicola, L	1
Schreiner, A	1
Hatzimichelakis, N; Kontomichalou, P; Makris, G; Paniara-Volika, O; Paraskevopoulou, E; Saroglou, G; Sima, A; Vassilopoulos, N	1
Parker, CW; Shatz, GS; Sullivan, TJ; Wedner, HJ; Yecies, LD	1
Ramirez, JA	1
Cavallo, J; Gidenne, S; Hernandez, E; Ramisse, F; van Delden, C	1
Collins, T; Gerding, DN	1
Craig, WA; Ebert, S; Fantin, B; Leggett, JE	1
Bass, JB; Nolan, PE	1
Drlicek, M; Kapfhammer, G; Vetter, N	1
DeJace, P; Klastersky, J	1
Segreti, J; Trenholme, GM	1
Nishino, T; Obana, Y; Tanino, T	1

Reviews

15 review(s) available for beta-lactams and Pneumonia

Article	Year
[Community-acquired pneumonia: selection of empirical treatment and sequential therapy. SARS-CoV-2 implications]. Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 2021, Volume: 34, Issue:6 Topics: beta-Lactams; Community-Acquired Infections; COVID-19; Humans; Pneumonia; SARS-CoV-2	2021
Empirical antibiotic treatment strategies for community-acquired pneumonia: a network meta-analysis. Journal of global antimicrobial resistance, 2022, Volume: 30 Topics: Anti-Bacterial Agents; beta-Lactams; Community-Acquired Infections; Drug Therapy, Combination; Fluoroquinolones; Humans; Network Meta-Analysis; Pneumonia	2022
A Review of the Resistance Mechanisms for Medicina (Kaunas, Lithuania), 2023, Oct-31, Volume: 59, Issue:11 Topics: Anti-Bacterial Agents; Anti-Infective Agents; Artificial Intelligence; beta-Lactams; Community-Acquired Infections; Drug Resistance, Bacterial; Fluoroquinolones; Humans; Macrolides; Pneumonia; Streptococcus pneumoniae	2023
Variation in Target Attainment of Beta-Lactam Antibiotic Dosing Between International Pediatric Formularies. Clinical pharmacology and therapeutics, 2021, Volume: 109, Issue:4 Topics: Adolescent; Anti-Bacterial Agents; Area Under Curve; Bacteriological Techniques; beta-Lactams; Child; Child, Preschool; Computer Simulation; Dose-Response Relationship, Drug; Drug Dosage Calculations; Humans; Infant; Infant, Newborn; Meningitis, Bacterial; Microbial Sensitivity Tests; Pediatrics; Pneumonia; Practice Guidelines as Topic; Sepsis; Socioeconomic Factors	2021
β-Lactam/macrolide dual therapy versus β-lactam monotherapy for the treatment of community-acquired pneumonia in adults: a systematic review and meta-analysis. The Journal of antimicrobial chemotherapy, 2014, Volume: 69, Issue:6 Topics: Adult; Anti-Bacterial Agents; beta-Lactams; Community-Acquired Infections; Drug Therapy, Combination; Humans; Macrolides; Odds Ratio; Pneumonia; Publication Bias; Treatment Outcome	2014
Ertapenem versus ceftriaxone for the treatment of complicated infections: a meta-analysis of randomized controlled trials. Chinese medical journal, 2014, Volume: 127, Issue:6 Topics: Anti-Bacterial Agents; beta-Lactams; Ceftriaxone; Ertapenem; Humans; Intraabdominal Infections; Pneumonia; Randomized Controlled Trials as Topic; Urinary Tract Infections	2014
Is β-Lactam Plus Macrolide More Effective than β-Lactam Plus Fluoroquinolone among Patients with Severe Community-Acquired Pneumonia?: a Systemic Review and Meta-Analysis. Journal of Korean medical science, 2017, Volume: 32, Issue:1 Topics: Anti-Bacterial Agents; beta-Lactams; Community-Acquired Infections; Databases, Factual; Drug Therapy, Combination; Fluoroquinolones; Humans; Intensive Care Units; Length of Stay; Macrolides; Odds Ratio; Pneumonia; Risk; Severity of Illness Index; Survival Analysis	2017
Respiratory fluoroquinolones for the treatment of community-acquired pneumonia: a meta-analysis of randomized controlled trials. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2008, Dec-02, Volume: 179, Issue:12 Topics: Anti-Bacterial Agents; beta-Lactams; Chi-Square Distribution; Community-Acquired Infections; Drug Therapy, Combination; Fluoroquinolones; Humans; Length of Stay; Macrolides; Odds Ratio; Pneumonia; Randomized Controlled Trials as Topic; Treatment Outcome	2008
Health economics of use fluoroquinolones to treat patients with community-acquired pneumonia. The American journal of medicine, 2010, Volume: 123, Issue:4 Suppl Topics: Administration, Oral; Anti-Bacterial Agents; beta-Lactams; Community-Acquired Infections; Drug Costs; Drug Therapy, Combination; Fluoroquinolones; Humans; Infusions, Intravenous; Length of Stay; Macrolides; Pneumonia; Severity of Illness Index; Treatment Outcome; United States	2010
Current guidelines for the treatment of severe pneumonia and sepsis. Chemotherapy, 2005, Volume: 51, Issue:5 Topics: Anti-Bacterial Agents; beta-Lactams; Community-Acquired Infections; Critical Illness; Cross Infection; Drug Resistance; Germany; Humans; Intensive Care Units; International Cooperation; Pneumonia; Practice Guidelines as Topic; Sepsis; Severity of Illness Index	2005
Switch therapy with beta-lactam/beta-lactamase inhibitors in patients with community-acquired pneumonia. The Annals of pharmacotherapy, 1998, Volume: 32, Issue:1 Topics: Administration, Oral; Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactams; Clinical Trials as Topic; Community-Acquired Infections; Drug Therapy, Combination; Enzyme Inhibitors; Humans; Injections, Intravenous; Patient Satisfaction; Pneumonia; Treatment Outcome	1998
Aminoglycosides versus beta-lactams in gram-negative pneumonia. Seminars in respiratory infections, 1991, Volume: 6, Issue:3 Topics: Aminoglycosides; Anti-Bacterial Agents; beta-Lactams; Bronchi; Drug Therapy, Combination; Gram-Negative Bacterial Infections; Humans; Pneumonia	1991
New drugs for treating lung infection. Chest, 1988, Volume: 94, Issue:5 Topics: 4-Quinolones; Anti-Bacterial Agents; Anti-Infective Agents; Antitubercular Agents; Antiviral Agents; beta-Lactamase Inhibitors; beta-Lactams; Drug Therapy, Combination; Humans; Pneumonia	1988
Comparative review of combination therapy: two beta-lactams versus beta-lactam plus aminoglycoside. The American journal of medicine, 1986, Jun-30, Volume: 80, Issue:6B Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Cellulitis; Clinical Trials as Topic; Drug Resistance, Microbial; Drug Therapy, Combination; Humans; Neoplasms; Neutropenia; Pneumonia; Pseudomonas Infections; Sepsis; Urinary Tract Infections	1986
Respiratory pharmacology. Antibiotics. I. Beta-lactam antibiotics, the tetracyclines, chloramphenicol, erythromycin, clindamycin, metronidazole, and the quinolones. Clinics in chest medicine, 1986, Volume: 7, Issue:3 Topics: Anti-Bacterial Agents; beta-Lactams; Chloramphenicol; Clindamycin; Erythromycin; Humans; Metronidazole; Pneumonia; Tetracyclines	1986

Trials

7 trial(s) available for beta-lactams and Pneumonia

Article	Year
Gastrointestinal Microbiome Disruption and Antibiotic-Associated Diarrhea in Children Receiving Antibiotic Therapy for Community-Acquired Pneumonia. The Journal of infectious diseases, 2022, 09-21, Volume: 226, Issue:6 Topics: Anti-Bacterial Agents; beta-Lactams; Child, Preschool; Community-Acquired Infections; Diarrhea; Gastrointestinal Microbiome; Humans; Infant; Pneumonia	2022
Comparison of the Respiratory Resistomes and Microbiota in Children Receiving Short versus Standard Course Treatment for Community-Acquired Pneumonia. mBio, 2022, 04-26, Volume: 13, Issue:2 Topics: Anti-Bacterial Agents; beta-Lactams; Child; Child, Preschool; Community-Acquired Infections; Humans; Infant; Microbiota; Pneumonia	2022
Accuracy of a score predicting the presence of an atypical pathogen in hospitalized patients with moderately severe community-acquired pneumonia. BMC infectious diseases, 2022, May-03, Volume: 22, Issue:1 Topics: Adult; Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; beta-Lactams; Community-Acquired Infections; Humans; Pneumonia	2022
Discontinuing β-lactam treatment after 3 days for patients with community-acquired pneumonia in non-critical care wards (PTC): a double-blind, randomised, placebo-controlled, non-inferiority trial. Lancet (London, England), 2021, 03-27, Volume: 397, Issue:10280 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; Child; Child, Preschool; Community-Acquired Infections; Double-Blind Method; Drug Administration Schedule; Drug Costs; Drug Resistance, Bacterial; Equivalence Trials as Topic; Female; Hospitalization; Humans; Infant; Infant, Newborn; Intention to Treat Analysis; Male; Middle Aged; Pneumonia; Treatment Outcome; Young Adult	2021
Atypical coverage in community-acquired pneumonia after outpatient beta-lactam monotherapy. Respiratory medicine, 2017, Volume: 129 Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; Community-Acquired Infections; Drug Therapy, Combination; Female; Fluoroquinolones; Hospitalization; Humans; Length of Stay; Macrolides; Male; Middle Aged; Netherlands; Outcome Assessment, Health Care; Pneumonia; Tetracycline; Treatment Outcome	2017
Treatment failure in pneumonia: impact of antibiotic treatment and cost analysis. The European respiratory journal, 2012, Volume: 39, Issue:3 Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Aza Compounds; beta-Lactams; Community-Acquired Infections; Drug Therapy, Combination; Female; Fluoroquinolones; Health Care Costs; Humans; Length of Stay; Macrolides; Male; Middle Aged; Moxifloxacin; Pneumonia; Quinolines; Treatment Failure	2012
Comparative review of combination therapy: two beta-lactams versus beta-lactam plus aminoglycoside. The American journal of medicine, 1986, Jun-30, Volume: 80, Issue:6B Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Cellulitis; Clinical Trials as Topic; Drug Resistance, Microbial; Drug Therapy, Combination; Humans; Neoplasms; Neutropenia; Pneumonia; Pseudomonas Infections; Sepsis; Urinary Tract Infections	1986

Other Studies

51 other study(ies) available for beta-lactams and Pneumonia

Article	Year
Effectiveness of Beta-Lactam plus Doxycycline for Patients Hospitalized with Community-Acquired Pneumonia. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2022, 08-24, Volume: 75, Issue:1 Topics: Anti-Bacterial Agents; beta-Lactams; Community-Acquired Infections; Doxycycline; Drug Therapy, Combination; Humans; Pneumonia; Retrospective Studies	2022
Clinical, radiological and pathological characteristics of moderate to fulminant psittacosis pneumonia. PloS one, 2022, Volume: 17, Issue:7 Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; Chlamydial Pneumonia; Chlamydophila psittaci; Humans; Hyperplasia; Middle Aged; Pneumonia; Psittacosis; Retrospective Studies	2022
Antimicrobial therapy of community-acquired pneumonia during stewardship efforts and a coronavirus pandemic: an observational study. BMC pulmonary medicine, 2022, Oct-14, Volume: 22, Issue:1 Topics: Anti-Bacterial Agents; Anti-Infective Agents; beta-Lactams; Community-Acquired Infections; Coronavirus; Humans; Pandemics; Pneumonia; Retrospective Studies	2022
Effects of reported beta-lactam allergies on pneumonia outcomes in lung transplant recipients. Transplant infectious disease : an official journal of the Transplantation Society, 2022, Volume: 24, Issue:5 Topics: Acute Kidney Injury; Anti-Bacterial Agents; Aztreonam; beta-Lactams; Carbapenems; Clostridium Infections; Drug Hypersensitivity; Fluoroquinolones; Humans; Hypersensitivity; Lung; Pneumonia; Retrospective Studies; Transplant Recipients	2022
Doxycycline vs. macrolides in combination with a β-lactam antibiotic for the treatment of community-acquired pneumonia in inpatients. European journal of medical research, 2022, Dec-08, Volume: 27, Issue:1 Topics: Anti-Bacterial Agents; beta-Lactams; Humans; Macrolides; Pneumonia; Retrospective Studies	2022
[Clarithromycin for community-acquired pneumonia in adults: focus on anti-inflammatory properties]. Terapevticheskii arkhiv, 2023, Jan-16, Volume: 94, Issue:12 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; C-Reactive Protein; Clarithromycin; Community-Acquired Infections; Female; Humans; Interleukin-6; Male; Middle Aged; Pneumonia; Tumor Necrosis Factor-alpha; Young Adult	2023
β-Lactams plus doxycycline versus azithromycin for treatment of severe community-acquired pneumonia in critically ill patients. The Journal of antimicrobial chemotherapy, 2023, Dec-01, Volume: 78, Issue:12 Topics: Adult; Anti-Bacterial Agents; Azithromycin; beta-Lactams; Community-Acquired Infections; Critical Illness; Doxycycline; Drug Therapy, Combination; Humans; Pneumonia; Prospective Studies; Treatment Outcome	2023
Empiric Anti-Pseudomonal β-Lactam Monotherapy Versus Fluoroquinolone Combination Therapy in Patients With Hospital-Acquired Pneumonia: A Multicenter Cohort Study With Propensity Score Matching. Journal of Korean medical science, 2023, Oct-23, Volume: 38, Issue:41 Topics: Adult; Anti-Bacterial Agents; beta-Lactams; Community-Acquired Infections; Drug Therapy, Combination; Fluoroquinolones; Hospitals; Humans; Pneumonia; Propensity Score; Retrospective Studies	2023
Fluoroquinolone Monotherapy and Combination of a Fluoroquinolone With a β-Lactam: Different Therapies for Different Types of Patients With Community-Acquired Pneumonia. Chest, 2019, Volume: 156, Issue:2 Topics: beta-Lactams; Community-Acquired Infections; Fluoroquinolones; Humans; Macrolides; Pneumonia	2019
Response. Chest, 2019, Volume: 156, Issue:2 Topics: Anti-Bacterial Agents; beta-Lactams; Community-Acquired Infections; Humans; Macrolides; Pneumonia	2019
Increased β-Lactams dosing regimens improve clinical outcome in critically ill patients with augmented renal clearance treated for a first episode of hospital or ventilator-acquired pneumonia: a before and after study. Critical care (London, England), 2019, Nov-27, Volume: 23, Issue:1 Topics: Adult; Anti-Bacterial Agents; beta-Lactams; Critical Illness; Dose-Response Relationship, Drug; Female; Healthcare-Associated Pneumonia; Humans; Male; Middle Aged; Pneumonia; Pneumonia, Ventilator-Associated; Retrospective Studies; Treatment Outcome	2019
Diagnosis and Treatment of Adults With Community-Acquired Pneumonia. JAMA, 2020, 03-03, Volume: 323, Issue:9 Topics: Adult; beta-Lactams; Community-Acquired Infections; Drug Resistance, Bacterial; Drug Therapy, Combination; Fluoroquinolones; Humans; Macrolides; Pneumonia; Streptococcus pneumoniae	2020
Investigations on Synergistic and Antioxidant Actions of Medicinal Plant- Based Biosynthesis of Zinc Oxide Nanoparticles Against E.coli and K. pneumonia Bacteria. Combinatorial chemistry & high throughput screening, 2022, Volume: 25, Issue:7 Topics: Anti-Bacterial Agents; Antioxidants; Bacteria; beta-Lactams; Ciprofloxacin; Escherichia coli; Metal Nanoparticles; Microbial Sensitivity Tests; Nanoparticles; Plant Extracts; Plants, Medicinal; Pneumonia; Zinc Oxide	2022
Outpatient antibiotic use attributable to viral acute lower respiratory tract infections during the cold season in France, 2010-2017. International journal of antimicrobial agents, 2021, Volume: 57, Issue:6 Topics: Aged; Anti-Bacterial Agents; Antimicrobial Stewardship; beta-Lactams; Bronchiolitis; Bronchitis; Child, Preschool; Emergency Service, Hospital; France; Humans; Inappropriate Prescribing; Influenza, Human; Macrolides; Outpatients; Pneumonia; Practice Patterns, Physicians'; Respiratory Tract Infections; Seasons; Virus Diseases	2021
Antibiotic resistance heterogeneity and LasR diversity within Pseudomonas aeruginosa populations from pneumonia in intensive care unit patients. International journal of antimicrobial agents, 2021, Volume: 57, Issue:6 Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactams; Bronchoalveolar Lavage; Ceftazidime; DNA, Bacterial; Drug Resistance, Bacterial; Genetic Variation; Humans; Imipenem; Intensive Care Units; Microbial Sensitivity Tests; Mutation; Pneumonia; Pseudomonas aeruginosa; Pseudomonas Infections; Quorum Sensing; Trans-Activators	2021
Association of Penicillin or Cephalosporin Allergy Documentation and Antibiotic Use in Hospitalized Patients with Pneumonia. The journal of allergy and clinical immunology. In practice, 2021, Volume: 9, Issue:8 Topics: Anti-Bacterial Agents; beta-Lactams; Cephalosporins; Cross-Sectional Studies; Documentation; Drug Hypersensitivity; Humans; Penicillins; Pneumonia; Retrospective Studies	2021
Macrolides and Pediatric Community-Acquired Pneumonia-Time for a Paradigm Shift? JAMA pediatrics, 2017, 12-01, Volume: 171, Issue:12 Topics: beta-Lactams; Child; Community-Acquired Infections; Humans; Macrolides; Pneumonia	2017
Empiric antibiotics for community-acquired pneumonia: A macrolide and a beta-lactam please! Respirology (Carlton, Vic.), 2018, Volume: 23, Issue:5 Topics: Anti-Bacterial Agents; beta-Lactams; Community-Acquired Infections; Drug Therapy, Combination; Humans; Macrolides; Pneumonia; Pneumonia, Bacterial	2018
Reconsidering Treatment of Community-Acquired Pneumonia: Are Macrolides Plus β-Lactams Essential? Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2018, 07-18, Volume: 67, Issue:3 Topics: Adult; Anti-Bacterial Agents; beta-Lactams; Community-Acquired Infections; Humans; Macrolides; Pneumonia; Streptococcus pneumoniae	2018
Effects of age, comorbidity and adherence to current antimicrobial guidelines on mortality in hospitalized elderly patients with community-acquired pneumonia. BMC infectious diseases, 2018, 04-24, Volume: 18, Issue:1 Topics: Aged; Aged, 80 and over; Anti-Infective Agents; beta-Lactams; China; Community-Acquired Infections; Comorbidity; Female; Fluoroquinolones; Guideline Adherence; Hospital Mortality; Humans; Male; Pneumonia; Retrospective Studies; Risk Factors	2018
Benzylpenicillin versus wide-spectrum beta-lactam antibiotics as empirical treatment of Haemophilus influenzae-associated lower respiratory tract infections in adults; a retrospective propensity score-matched study. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2018, Volume: 37, Issue:9 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Child; Child, Preschool; Community-Acquired Infections; Female; Haemophilus Infections; Haemophilus influenzae; Hospitalization; Humans; Infant; Infant, Newborn; Male; Microbial Sensitivity Tests; Middle Aged; Penicillin G; Pneumonia; Propensity Score; Respiratory Tract Infections; Retrospective Studies; Sweden; Young Adult	2018
Antibiotic treatment outcomes in community-acquired pneumonia Turkish journal of medical sciences, 2018, Aug-16, Volume: 48, Issue:4 Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; Community-Acquired Infections; Drug Therapy, Combination; Female; Fluoroquinolones; Hospital Departments; Hospital Mortality; Hospitals; Humans; Length of Stay; Macrolides; Male; Middle Aged; Pneumonia; Prospective Studies; Pseudomonas aeruginosa; Streptococcus pneumoniae; Treatment Outcome; Turkey	2018
Prescribing trends and revisit rates following a pharmacist-driven protocol change for community-acquired pneumonia in an emergency department. The International journal of pharmacy practice, 2019, Volume: 27, Issue:3 Topics: Adult; Aged; Anti-Bacterial Agents; beta-Lactams; Community-Acquired Infections; Drug Prescriptions; Drug Therapy, Combination; Emergency Service, Hospital; Female; Humans; Macrolides; Male; Middle Aged; Patient Readmission; Pharmacists; Pneumonia; Practice Patterns, Physicians'; Retrospective Studies	2019
β-lactam monotherapy is non-inferior to combination treatment for community-acquired pneumonia. The Lancet. Respiratory medicine, 2015, Volume: 3, Issue:5 Topics: beta-Lactams; Community-Acquired Infections; Drug Therapy, Combination; Fluoroquinolones; Humans; Macrolides; Pneumonia; Randomized Controlled Trials as Topic	2015
[ACUTE RESPIRATORY DISTRESS SYNDROME CAUSED BY BETA-LACTAM ANTIBIOTICS]. Klinicheskaia meditsina, 2015, Volume: 93, Issue:8 Topics: Anti-Bacterial Agents; beta-Lactams; Follow-Up Studies; Glucocorticoids; Humans; Male; Middle Aged; Pneumonia; Prednisolone; Radiography, Thoracic; Respiratory Distress Syndrome	2015
The use of ertapenem for the treatment of community-acquired pneumonia in routine hospital practice: a matched cohort study. Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 2016, Volume: 29, Issue:5 Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; Cohort Studies; Community-Acquired Infections; Comorbidity; Ertapenem; Female; Frail Elderly; Hospitalization; Humans; Male; Middle Aged; Nursing Homes; Pneumonia; Retrospective Studies; Risk Factors	2016
Implication of clinical pathway care for community-acquired pneumonia in a community hospital: early switch from an intravenous beta-lactam plus a macrolide to an oral respiratory fluoroquinolone. Internal medicine (Tokyo, Japan), 2008, Volume: 47, Issue:21 Topics: Administration, Inhalation; Administration, Oral; Aged; Aged, 80 and over; beta-Lactams; Cohort Studies; Community-Acquired Infections; Critical Pathways; Drug Therapy, Combination; Female; Fluoroquinolones; Hospitals, Community; Humans; Infusions, Intravenous; Macrolides; Male; Middle Aged; Pneumonia; Retrospective Studies	2008
Treatment of community-acquired pneumonia. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2008, Dec-02, Volume: 179, Issue:12 Topics: Anti-Bacterial Agents; beta-Lactams; Community-Acquired Infections; Drug Resistance, Bacterial; Fluoroquinolones; Humans; Macrolides; Pneumonia	2008
Levofloxacin-induced delirium. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2009, Volume: 30, Issue:2 Topics: Age Factors; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; beta-Lactams; Brain; Clarithromycin; Confusion; Delirium; Ertapenem; Hallucinations; Humans; Levofloxacin; Male; Ofloxacin; Pneumonia; Risk Factors; Sex Factors; Time Factors; Withholding Treatment	2009
Feedback dose alteration significantly affects probability of pathogen eradication in nosocomial pneumonia. The European respiratory journal, 2009, Volume: 34, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Aminoglycosides; beta-Lactams; Cross Infection; Female; Fluoroquinolones; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Pneumonia; Time Factors; Treatment Outcome	2009
Clinical response to ertapenem in severe community-acquired pneumonia: a retrospective series in an elderly population. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2009, Volume: 15, Issue:11 Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; Case-Control Studies; Community-Acquired Infections; Ertapenem; Female; Hospitals; Humans; Length of Stay; Male; Pneumonia; Retrospective Studies; Severity of Illness Index; Spain; Treatment Outcome	2009
Impact of macrolide therapy on mortality in severe sepsis caused by pneumonia. The European respiratory journal, 2009, Volume: 34, Issue:2 Topics: Anti-Bacterial Agents; beta-Lactams; Bronchiolitis; Community-Acquired Infections; Critical Care; Cystic Fibrosis; Humans; Inflammation; Macrolides; Pneumonia; Randomized Controlled Trials as Topic; Sepsis; Treatment Outcome	2009
Improving outcomes in elderly patients with community-acquired pneumonia by adhering to national guidelines: Community-Acquired Pneumonia Organization International cohort study results. Archives of internal medicine, 2009, Sep-14, Volume: 169, Issue:16 Topics: Aged; Aged, 80 and over; Anti-Infective Agents; beta-Lactams; Cohort Studies; Community-Acquired Infections; Drug Therapy, Combination; Female; Guideline Adherence; Humans; Length of Stay; Male; Pneumonia; Retrospective Studies	2009
Pseudomonas aeruginosa OspR is an oxidative stress sensing regulator that affects pigment production, antibiotic resistance and dissemination during infection. Molecular microbiology, 2010, Volume: 75, Issue:1 Topics: Amino Acid Substitution; Animals; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactams; Female; Gene Deletion; Gene Expression Regulation, Bacterial; Glutathione Peroxidase; Hydrogen Peroxide; Mice; Mice, Inbred C57BL; Models, Biological; Mutagenesis, Site-Directed; Oxidative Stress; Pigments, Biological; Pneumonia; Pseudomonas aeruginosa; Pseudomonas Infections; Quorum Sensing; Repressor Proteins; Signal Transduction; Stress, Physiological; Tyrosine; Virulence	2010
Q: Are antibiotics indicated for the treatment of aspiration pneumonia? Cleveland Clinic journal of medicine, 2010, Volume: 77, Issue:9 Topics: Anti-Bacterial Agents; beta-Lactams; Clindamycin; Humans; Metronidazole; Pneumonia; Pneumonia, Aspiration; Pneumonia, Bacterial	2010
Does radiographic evidence of prior pulmonary tubercular infection influence the choice of empiric antibiotics for community-acquired pneumonia in a tuberculosis-endemic area? Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, 2010, Volume: 43, Issue:5 Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; Clinical Protocols; Community-Acquired Infections; Comorbidity; Endemic Diseases; Fluoroquinolones; Humans; Middle Aged; Pneumonia; Radiography; Retrospective Studies; Treatment Outcome; Tuberculosis	2010
Variability in pediatric infectious disease consultants' recommendations for management of community-acquired pneumonia. PloS one, 2011, Volume: 6, Issue:5 Topics: Anti-Bacterial Agents; beta-Lactams; Clindamycin; Community-Acquired Infections; Data Collection; Humans; Methicillin-Resistant Staphylococcus aureus; Pneumonia; Vancomycin	2011
Prevalence and characterization of plasmid-mediated blaESBL with their genetic environment in Escherichia coli and Klebsiella pneumoniae in patients with pneumonia. Chinese medical journal, 2012, Volume: 125, Issue:5 Topics: beta-Lactams; Blotting, Southern; Escherichia coli; Klebsiella pneumoniae; Plasmids; Pneumonia; Promoter Regions, Genetic; Prospective Studies	2012
Severe community-acquired pneumonia treated with β-lactam-respiratory quinolone vs. β-lactam-macrolide combination. Acta anaesthesiologica Scandinavica, 2013, Volume: 57, Issue:5 Topics: Adult; Aged; Anti-Bacterial Agents; beta-Lactams; Cohort Studies; Community-Acquired Infections; Drug Therapy, Combination; Female; Humans; Macrolides; Male; Middle Aged; Pneumonia; Quinolones; Retrospective Studies; Severity of Illness Index; Treatment Outcome	2013
Ertapanem therapy for community-acquired pneumonia in the elderly. Journal of the American Geriatrics Society, 2004, Volume: 52, Issue:10 Topics: Aged; beta-Lactams; Community-Acquired Infections; Ertapenem; Humans; Lactams; Pneumonia	2004
A survey on antibiotic usage in dairy herds in Pennsylvania. Journal of dairy science, 2005, Volume: 88, Issue:8 Topics: Animals; Anti-Bacterial Agents; beta-Lactams; Cattle; Cattle Diseases; Cephalosporins; Dairying; Drug Residues; Drug Resistance, Bacterial; Endometritis; Enteritis; Female; Foot Diseases; Mastitis, Bovine; Milk; Pennsylvania; Pneumonia; Surveys and Questionnaires; Tetracyclines	2005
[Initial treatment can lighten low-severity community-acquired pneumonia]. Medizinische Monatsschrift fur Pharmazeuten, 2005, Volume: 28, Issue:11 Topics: Anti-Bacterial Agents; beta-Lactams; Community-Acquired Infections; Humans; Pneumonia	2005
In vitro evaluation of antibiotics' combinations for empirical therapy of suspected methicillin resistant Staphylococcus aureus severe respiratory infections. BMC infectious diseases, 2007, Sep-21, Volume: 7 Topics: Amikacin; Anti-Bacterial Agents; beta-Lactams; Drug Therapy, Combination; Humans; Levofloxacin; Methicillin Resistance; Microbial Sensitivity Tests; Mutation; Ofloxacin; Pneumonia; Respiratory Tract Infections; Staphylococcal Infections; Staphylococcus aureus; Teicoplanin; Vancomycin	2007
Beta-lactam antibiotics in lower respiratory tract infections. Scandinavian journal of infectious diseases. Supplementum, 1984, Volume: 42 Topics: Adult; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Bronchitis; Humans; Penicillins; Pneumonia; Respiratory Tract Infections	1984
Amoxicillin and clavulanic acid combination: clinical and laboratory evaluation in pulmonary infections. Clinical therapeutics, 1982, Volume: 4, Issue:6 Topics: Adult; Aged; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; beta-Lactamases; beta-Lactams; Bronchitis; Clavulanic Acid; Drug Combinations; Humans; Microbial Sensitivity Tests; Middle Aged; Pneumonia	1982
Desensitization of patients allergic to penicillin using orally administered beta-lactam antibiotics. The Journal of allergy and clinical immunology, 1982, Volume: 69, Issue:3 Topics: Administration, Oral; Adolescent; Adult; Aged; Anti-Bacterial Agents; beta-Lactams; Carbenicillin; Desensitization, Immunologic; Drug Hypersensitivity; Endocarditis, Bacterial; Female; Humans; Male; Middle Aged; Oxacillin; Penicillins; Pneumonia; Pseudomonas Infections; Staphylococcal Infections	1982
Decreased virulence of a strain of Pseudomonas aeruginosa O12 overexpressing a chromosomal type 1 beta-lactamase could be due to reduced expression of cell-to-cell signaling dependent virulence factors. FEMS immunology and medical microbiology, 2000, Volume: 28, Issue:3 Topics: Alginates; Animals; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Decanoates; Drug Resistance, Microbial; Endopeptidases; Female; Glucuronic Acid; Hexuronic Acids; Humans; Mice; Mice, Inbred BALB C; Pancreatic Elastase; Pneumonia; Pseudomonas aeruginosa; Pseudomonas Infections; Rhamnose; Virulence	2000
Ertapenem (Invanz)--a new parenteral carbapenem. The Medical letter on drugs and therapeutics, 2002, Mar-18, Volume: 44, Issue:1126 Topics: Anti-Bacterial Agents; beta-Lactams; Clinical Trials as Topic; Community-Acquired Infections; Dose-Response Relationship, Drug; Ertapenem; Gram-Negative Bacterial Infections; Humans; Infusions, Parenteral; Injections, Intramuscular; Injections, Intravenous; Lactams; Pneumonia; Urinary Tract Infections	2002
Comparative dose-effect relations at several dosing intervals for beta-lactam, aminoglycoside and quinolone antibiotics against gram-negative bacilli in murine thigh-infection and pneumonitis models. Scandinavian journal of infectious diseases. Supplementum, 1990, Volume: 74 Topics: 4-Quinolones; Aminoglycosides; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Infections; beta-Lactams; Disease Models, Animal; Dose-Response Relationship, Drug; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Gram-Negative Bacteria; Least-Squares Analysis; Mice; Mice, Inbred ICR; Pneumonia; Pseudomonas aeruginosa; Pseudomonas Infections; Specific Pathogen-Free Organisms	1990
[Infections of the lower respiratory tract--effectiveness of beta- lactam antibiotics on bacterial isolates from sputum and bronchial secretions]. Praxis und Klinik der Pneumologie, 1988, Volume: 42, Issue:7 Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Drug Resistance, Microbial; Humans; Pneumonia; Sputum	1988
Therapeutic efficacy of beta-lactam and aminoglycoside antibiotics on experimental pneumonia caused by Klebsiella pneumoniae B-54 in diabetic mice. The Journal of antibiotics, 1985, Volume: 38, Issue:7 Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; beta-Lactams; Diabetes Mellitus, Experimental; Drug Resistance, Microbial; Klebsiella Infections; Klebsiella pneumoniae; Male; Mice; Pneumonia	1985